logo

For the Inventor, By the Inventor

West Malling, United Kingdom

Aventis Pharma Limited


USPTO Granted Patents = 39

% Expired Patents = 30.8



Forward Citations = 1,012

Loading Chart...
Loading Chart...

82 inventors (with patents filed for the assignee):

goldMedal Andrew David Morley (9 out of 30 patents)

silverMedal Garry Fenton (8 out of 17 patents)

bronzeMedal Neil Victor Harris (7 out of 15 patents)

4.  Tahir Nadeem Majid (6 out of 13 patents)

5.  Duncan Grant Young (6 out of 7 patents)

6.  Stephen John Minshull (6 out of 8 patents)

7.  Malcolm Norman Palfreyman (5 out of 12 patents)

8.  Paul Robert Eastwood (5 out of 5 patents)

9.  Paul Joseph Cox (5 out of 11 patents)

10.  Peter Charles Astles (4 out of 9 patents)

11.  Clive McCarthy (4 out of 9 patents)

12.  David Edward Clark (4 out of 4 patents)

13.  Simon Paul Wells (4 out of 4 patents)

14.  Graham Keith Lacy (3 out of 36 patents)

15.  Frank Halley (3 out of 34 patents)


Core Competencies:
Inhaler
PDE IV Inhibitors
TNF Inhibitors
Aerosol Dispenser
Milling Process
Capsule Opening
Substituted Compounds
Pharmaceutical Compositions
Mechanical Dose Counter
Human Antithrombin Variants
Integrin Antagonists
Abuse Resistant Tablets

39 patents:

1. 9295793 - Inhaler device and method of administering a medicament (2016-03-29),
2. 8129537 - Compounds as PDE IV and TNF inhibitors (2012-03-06),
3. 8083127 - Slave wheel counter mechanism useable with an inhaler (2011-12-27),
4. 7827989 - Mechanical doses counter for a powder inhaler (2010-11-09),
5. 7726555 - Slave wheel counter mechanism useable with an inhaler (2010-06-01),
6. 7652144 - Compounds as PDE IV and TNF inhibitors (2010-01-26),
7. 7479501 - Heteroaryl-cyclic acetals (2009-01-20),
8. 7329675 - Substituted azabicyclic compounds (2008-02-12),
9. 7322352 - Inhaler (2008-01-29),
10. 7227020 - Azaindoles (2007-06-05),
11. 7211586 - Substituted tetrahydroisoquinolines (2007-05-01),
12. 7208598 - Derivatives of purine, their preparation process and pharmaceutical compositions containing them (2007-04-24),
13. 7166616 - Substituted alkanoic acids (2007-01-23),
14. 7045660 - Compounds as PDE IV and TNF-inhibitors (2006-05-16),
15. 7041318 - Milling process for the production of finely milled medicinal substances (2006-05-09),
Company Overview
Aventis Pharma Limited is a pharmaceutical company based in West Malling, UK, specializing in the development and manufacturing of innovative healthcare solutions. The organization focuses on a wide range of therapeutic areas, including oncology, cardiology, and infectious diseases, leveraging advanced research methodologies and technologies to enhance patient outcomes. With a commitment to quality and efficacy, Aventis Pharma aims to address unmet medical needs through its diverse portfolio of products and ongoing research initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

39 Patents

#1 in West Malling

#452 in United Kingdom

#17,448 in the World

West Malling, GB
West Malling, United Kingdom

Aventis Pharma Limited

Forward Citations = 1,012

82 inventors:

goldMedal Andrew David Morley (9 out of 30 patents)

silverMedal Garry Fenton (8 out of 17 patents)

bronzeMedal Neil Victor Harris (7 out of 15 patents)

4.  Tahir Nadeem Majid (6 out of 13 patents)

5.  Duncan Grant Young (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aventis Pharma Limited. Retrieved from https://idiyas.com/company/aventis-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…